Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

When an obscurity becomes trend: social-media descriptions of tianeptine use and associated atypical drug use
Kirsten E. Smith, Jeffrey M. Rogers, Justin C. Strickland, et al.
The American Journal of Drug and Alcohol Abuse (2021) Vol. 47, Iss. 4, pp. 455-466
Open Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

An update on the clinical pharmacology of kratom: uses, abuse potential, and future considerations
Christopher R. McCurdy, Abhisheak Sharma, Kirsten E. Smith, et al.
Expert Review of Clinical Pharmacology (2024) Vol. 17, Iss. 2, pp. 131-142
Closed Access | Times Cited: 18
Therapeutic benefit with caveats?: Analyzing social media data to understand the complexities of kratom use
Kirsten E. Smith, Jeffrey M. Rogers, Destiny Schriefer, et al.
Drug and Alcohol Dependence (2021) Vol. 226, pp. 108879-108879
Open Access | Times Cited: 56
Understanding Kratom Use: A Guide for Healthcare Providers
Marc T. Swogger, Kirsten E. Smith, Albert Garcia‐Romeu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 52
Kratom use as more than a “self-treatment”
Kirsten E. Smith, Kelly E. Dunn, Jeffrey M. Rogers, et al.
The American Journal of Drug and Alcohol Abuse (2022) Vol. 48, Iss. 6, pp. 684-694
Closed Access | Times Cited: 37
Searching for a Signal: Self-Reported Kratom Dose-Effect Relationships Among a Sample of US Adults With Regular Kratom Use Histories
Kirsten E. Smith, Jeffrey M. Rogers, Kelly E. Dunn, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 36
Investigating Substance Use via Reddit: Systematic Scoping Review
Yu Chi, Huai-yu Chen
Journal of Medical Internet Research (2023) Vol. 25, pp. e48905-e48905
Open Access | Times Cited: 17
Growing pains with kratom: experiences discussed in subreddits contrast with satisfaction expressed in surveys
Jeffrey M. Rogers, Kayla Colvin, David H. Epstein, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 6
Social, psychological, and substance use characteristics of U.S. adults who use kratom: Initial findings from an online, crowdsourced study.
Kirsten E. Smith, Kelly E. Dunn, Oliver Grundmann, et al.
Experimental and Clinical Psychopharmacology (2021) Vol. 30, Iss. 6, pp. 983-996
Open Access | Times Cited: 40
At least four groups of kratom consumers in the United States: latent-class analysis of motivations for kratom use
Katherine Hill, Jeffrey M. Rogers, Oliver Grundmann, et al.
The American Journal of Drug and Alcohol Abuse (2025), pp. 1-13
Open Access
Commentary on Tianeptine Exposures Reported to United States Poison Centers, 2015–2023
William Rushton, Jessica Rivera, Scott R. Harris
Journal of Medical Toxicology (2025)
Closed Access
Ginkgo Biloba as a niche theme cognitive enhancer agent, 1420 dokumen of Scopus database. A bibliometric study from 1988 to 2024
ARMAN YURISALDI SALEH, Dwi Arwandi Yogi Saputra, Riezky Valentina, et al.
F1000Research (2025) Vol. 14, pp. 275-275
Open Access
Systematic Review of Clinical Case Reports Involving Tianeptine Products: “Gas Station Heroin” Hype or Fact?
Kirsten E. Smith, Jeffrey D. Feldman, Caroline Freinberg, et al.
Current Addiction Reports (2025) Vol. 12, Iss. 1
Closed Access
Tianeptine, an Antidepressant with Opioid Agonist Effects: Pharmacology and Abuse Potential, a Narrative Review
Amber N. Edinoff, Saveen Sall, Scott P. Beckman, et al.
Pain and Therapy (2023) Vol. 12, Iss. 5, pp. 1121-1134
Open Access | Times Cited: 11
Kratom Use in the US: Both a Regional Phenomenon and a White Middle-Class Phenomenon? Evidence From NSDUH 2019 and an Online Convenience Sample
Jeffrey M. Rogers, Kirsten E. Smith, Justin C. Strickland, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 25
Kratom’s Emergence and Persistence Within the US Polydrug Epidemic
Kirsten E. Smith, Jeffrey M. Rogers, Jeffrey D. Feldman
Current Addiction Reports (2023) Vol. 10, Iss. 2, pp. 262-271
Open Access | Times Cited: 10
Novel methods for the remote investigation of emerging substances: Application to kratom.
Kirsten E. Smith, Jeffrey D. Feldman, Kelly E. Dunn, et al.
Experimental and Clinical Psychopharmacology (2023) Vol. 32, Iss. 2, pp. 215-227
Open Access | Times Cited: 10
How Essential is Kratom Availability and use during COVID-19? Use Pattern Analysis Based on Survey and Social Media Data
Oliver Grundmann, Charles A. Veltri, Diana Morcos, et al.
Substance Abuse (2022) Vol. 43, Iss. 1, pp. 865-877
Open Access | Times Cited: 13
Opioid-like adverse effects of tianeptine in male rats and mice
Tyson R. Baird, Hamid I. Akbarali, William L. Dewey, et al.
Psychopharmacology (2022) Vol. 239, Iss. 7, pp. 2187-2199
Open Access | Times Cited: 13
Kava (Piper methysticum) in the United States: the quiet rise of a substance with often subtle effects
Salma Pont-Fernandez, Marina Kheyfets, Jeffrey M. Rogers, et al.
The American Journal of Drug and Alcohol Abuse (2022) Vol. 49, Iss. 1, pp. 85-96
Closed Access | Times Cited: 11
Associations of Lifetime Nonmedical Opioid, Methamphetamine, and Kratom Use within a Nationally Representative US Sample
Kirsten E. Smith, Jeffrey M. Rogers, Justin C. Strickland
Journal of Psychoactive Drugs (2021) Vol. 54, Iss. 5, pp. 429-439
Open Access | Times Cited: 13
From Antidepressant Tianeptine to Street Drug ZaZa: A Narrative Review
Morgan Wagner, Joseph V. Pergolizzi, Jo Ann LeQuang, et al.
Cureus (2023)
Open Access | Times Cited: 5
Tianeptine Exposures Reported to United States Poison Centers, 2015–2023
Mohammad Morshedul Quadir, Natalie I. Rine, Jaahnavi Badeti, et al.
Journal of Medical Toxicology (2024)
Closed Access | Times Cited: 1
Microdose Induction of Buprenorphine in a Patient Using Tianeptine
Laura M. Szczesniak, Ross Sullivan
Journal of Addiction Medicine (2022) Vol. 16, Iss. 6, pp. 736-738
Closed Access | Times Cited: 7
Severe tianeptine withdrawal symptoms managed with medications for opioid use disorder: a case report
Varun Rawal, Matthew Gallardo, Katelyn Henderson, et al.
Journal of Addictive Diseases (2023) Vol. 43, Iss. 1, pp. 98-103
Open Access | Times Cited: 3
For Better or Worse: Self-reported Changes in Kratom and Other Substance Use as a Result of the COVID-19 Pandemic
Jeffrey M. Rogers, Kirsten E. Smith, Destiny Schriefer, et al.
Substance Abuse Research and Treatment (2022) Vol. 16, pp. 117822182211239-117822182211239
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top